• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX 0.23% $12.89

TELIX PHARMACEUTICALS LIMITED - Announcements

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The Company is developing a portfolio of clinical-stage products that focuses to address the unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). The Company’s lead programs include TLX591-CDx (Illuccix) / TLX591 for diagnosis and treatment of metastatic castrate-resistant prostate cancer, TLX250-CDx/TLX250 for diagnosis and treatment of renal (kidney) cancer, TLX101-CDx / TLX101 for diagnosis and treatment of glioblastoma (brain cancer), and TLX66-CDx (Scintimun) / TLX66 for the treatment of bone marrow conditioning and rare diseases. The Company also owns SENSEI radio-guided surgery business.More

Announcements


TLX Notification regarding unquoted securities - TLX27/03/24 download Created with Sketch. 17.27KB
TLX Cleansing Notice21/03/24 download Created with Sketch. 141.56KB
TLX Application for quotation of securities - TLX21/03/24 download Created with Sketch. 15.75KB
TLX Appointment of Darren Patti to Group Chief Operating Officer12/03/24 download Created with Sketch. 134.78KB
TLX Telix Notice of General Meeting, Proxy Form and Online Guide06/03/24 download Created with Sketch. 4.52MB
TLX Proposed issue of securities - TLX05/03/24 download Created with Sketch. 15.86KB
TLX Presentation to Accompany ARTMS AcquisitionPRICE SENSITIVE05/03/24 download Created with Sketch. 1.14MB
TLX Telix to Acquire ARTMS (Isotope Production Platform)PRICE SENSITIVE05/03/24 download Created with Sketch. 224.66KB
TLX Proposed issue of securities - TLX27/02/24 download Created with Sketch. 15.73KB
TLX Telix to Acquire IsoTherapeutics (US R&D and Manufacturing)PRICE SENSITIVE27/02/24 download Created with Sketch. 149.36KB
TLX Appendix 4G and 2023 Corporate Governance Statement22/02/24 download Created with Sketch. 1.78MB
TLX 2023 Full Year Results PresentationPRICE SENSITIVE22/02/24 download Created with Sketch. 1.33MB
TLX 2023 Full Year Results ReleasePRICE SENSITIVE22/02/24 download Created with Sketch. 86.93KB
TLX Appendix 4E and 2023 Annual ReportPRICE SENSITIVE22/02/24 download Created with Sketch. 12.48MB
TLX Cleansing Notice09/02/24 download Created with Sketch. 138.55KB
TLX Application for quotation of securities - TLX09/02/24 download Created with Sketch. 15.76KB
TLX Proposed issue of securities - TLX08/02/24 download Created with Sketch. 19.52KB
TLX Presentation to Accompany QSAM AcquisitionPRICE SENSITIVE08/02/24 download Created with Sketch. 944.1KB
TLX Telix Acquires QSAM and its Bone Cancer Targeting PlatformPRICE SENSITIVE08/02/24 download Created with Sketch. 214.84KB
TLX Telix 2023 Full Year Results and Investor Webcast/Call07/02/24 download Created with Sketch. 138.36KB
TLX Appendix 3Y Change in Director Interests - C Behrenbruch22/01/24 download Created with Sketch. 286.35KB
TLX Cleansing Notice22/01/24 download Created with Sketch. 142.52KB
TLX Application for quotation of securities - TLX22/01/24 download Created with Sketch. 25.63KB
TLX JP Morgan Healthcare Conference PresentationPRICE SENSITIVE08/01/24 download Created with Sketch. 2.11MB
TLX JP Morgan Healthcare Conference and Trading UpdatePRICE SENSITIVE08/01/24 download Created with Sketch. 175.38KB
TLX Notification regarding unquoted securities - TLX08/01/24 download Created with Sketch. 28.56KB
TLX Notification of cessation of securities - TLX08/01/24 download Created with Sketch. 22.34KB
TLX Telix Plans U.S. Registered Public Offering and ListingPRICE SENSITIVE05/01/24 download Created with Sketch. 122.95KB
TLX Cleansing Notice22/12/23 download Created with Sketch. 142.68KB
TLX Application for quotation of securities - TLX22/12/23 download Created with Sketch. 27.82KB
TLX Appointment of Dr David Cade to Group Chief Medical Officer20/12/23 download Created with Sketch. 124.77KB
TLX Telix Submits BLA for TLX250-CDx for Kidney Cancer ImagingPRICE SENSITIVE19/12/23 download Created with Sketch. 187.02KB
TLX Update on Financial Reporting Requirements18/12/23 download Created with Sketch. 117.69KB
TLX Cleansing Notice30/11/23 download Created with Sketch. 141.14KB
TLX Application for quotation of securities - TLX30/11/23 download Created with Sketch. 25.03KB
TLX Telix ProstACT (TLX591) Expert Forum - Webcast Notification16/11/23 download Created with Sketch. 133.79KB
TLX Telix Announces Proposed Acquisition of QSAM BiosciencesPRICE SENSITIVE14/11/23 download Created with Sketch. 141.84KB
TLX First Patient Dosed in Ph III ProstACT GLOBAL Therapy StudyPRICE SENSITIVE13/11/23 download Created with Sketch. 141.54KB
TLX Cleansing Notice10/11/23 download Created with Sketch. 143.09KB
TLX Application for quotation of securities - TLX10/11/23 download Created with Sketch. 27.88KB
TLX Notification regarding unquoted securities - TLX02/11/23 download Created with Sketch. 28.14KB
TLX Cleansing Notice02/11/23 download Created with Sketch. 113.82KB
TLX Application for quotation of securities - TLX02/11/23 download Created with Sketch. 25.51KB
TLX Telix Completes Acquisition of Lightpoint MedicalPRICE SENSITIVE01/11/23 download Created with Sketch. 152.76KB
TLX ProstACT SELECT Study of TLX591 Positive Interim ReadoutPRICE SENSITIVE19/10/23 download Created with Sketch. 1.12MB
TLX Q3 2023 Business Update to Accompany Quarterly ResultsPRICE SENSITIVE18/10/23 download Created with Sketch. 1.33MB
TLX Activities Report and Appendix 4C - September 2023 QuarterPRICE SENSITIVE18/10/23 download Created with Sketch. 179.15KB
TLX Notification of cessation of securities - TLX13/10/23 download Created with Sketch. 22.37KB
TLX Cleansing Notice13/10/23 download Created with Sketch. 142.64KB
TLX Application for quotation of securities - TLX13/10/23 download Created with Sketch. 27.79KB
TLX Notification of upcoming quarterly results and investor call11/10/23 download Created with Sketch. 127.01KB
TLX Cleansing Notice27/09/23 download Created with Sketch. 143.1KB
TLX Application for quotation of securities - TLX27/09/23 download Created with Sketch. 28.44KB
TLX Cleansing Notice06/09/23 download Created with Sketch. 142.93KB
TLX Application for quotation of securities - TLX06/09/23 download Created with Sketch. 32.13KB
TLX 1H 2023 Results PresentationPRICE SENSITIVE23/08/23 download Created with Sketch. 2.12MB
TLX 1H 2023 Results ReleasePRICE SENSITIVE23/08/23 download Created with Sketch. 82.77KB
TLX 1H 2023 Appendix 4D and Interim ReportPRICE SENSITIVE23/08/23 download Created with Sketch. 1.5MB
TLX Cleansing Notice16/08/23 download Created with Sketch. 140.39KB
TLX Application for quotation of securities - TLX16/08/23 download Created with Sketch. 25.04KB
TLX Telix Half Year Results and Investor Conference Call Details15/08/23 download Created with Sketch. 126.31KB
TLX First Patient Dosed in Phase 3 Illuccix China StudyPRICE SENSITIVE11/08/23 download Created with Sketch. 132.49KB
TLX Cleansing Notice27/07/23 download Created with Sketch. 142.08KB
TLX Application for quotation of securities - TLX27/07/23 download Created with Sketch. 25.2KB
TLX Q2 2023 Business Update to Accompany Quarterly ResultsPRICE SENSITIVE19/07/23 download Created with Sketch. 2.54MB
TLX Activities Report and Appendix 4C - June 2023 QuarterPRICE SENSITIVE19/07/23 download Created with Sketch. 191.79KB
TLX Notification of upcoming quarterly results and investor call13/07/23 download Created with Sketch. 127.16KB
TLX Notification of cessation of securities - TLX10/07/23 download Created with Sketch. 24.63KB
TLX Notification regarding unquoted securities - TLX10/07/23 download Created with Sketch. 28.7KB
TLX Cleansing Notice28/06/23 download Created with Sketch. 140.74KB
TLX Application for quotation of securities - TLX28/06/23 download Created with Sketch. 27.59KB
TLX Proposed issue of securities - TLX21/06/23 download Created with Sketch. 30.41KB
TLX Lightpoint Acquisition to Expand Telix Urologic PipelinePRICE SENSITIVE21/06/23 download Created with Sketch. 204.7KB
TLX Telix Urology Innovation Showcase21/06/23 download Created with Sketch. 138.59KB
TLX Phase II study for indication expansion of TLX250-CDx dosesPRICE SENSITIVE19/06/23 download Created with Sketch. 131.12KB
TLX Appendix 3Y Change in Director Interests - C Behrenbruch02/06/23 download Created with Sketch. 326.45KB
TLX Notification regarding unquoted securities - TLX02/06/23 download Created with Sketch. 27.51KB
TLX Cleansing Notice02/06/23 download Created with Sketch. 140.7KB
TLX Application for quotation of securities - TLX02/06/23 download Created with Sketch. 27.81KB
TLX Securities Dealing Policy - updated30/05/23 download Created with Sketch. 273.39KB
TLX Results of Annual General Meeting24/05/23 download Created with Sketch. 156.03KB
TLX Annual General Meeting - PresentationPRICE SENSITIVE24/05/23 download Created with Sketch. 1.47MB
TLX Annual General Meeting - Chairman and CEO AddressesPRICE SENSITIVE24/05/23 download Created with Sketch. 243.86KB
TLX Notification regarding unquoted securities - TLX05/05/23 download Created with Sketch. 27.67KB
TLX Cleansing Notice02/05/23 download Created with Sketch. 143.54KB
TLX Application for quotation of securities - TLX02/05/23 download Created with Sketch. 34.74KB
TLX Cleansing Notice01/05/23 download Created with Sketch. 139.17KB
TLX Application for quotation of securities - TLX01/05/23 download Created with Sketch. 343.52KB
TLX ZIRCON Data Presented at AUA Confirms Efficacy in 2cm MassesPRICE SENSITIVE01/05/23 download Created with Sketch. 128.28KB
TLX Proposed issue of securities - TLX27/04/23 download Created with Sketch. 24.75KB
TLX Presentation to Accompany AI Development Program UpdatePRICE SENSITIVE27/04/23 download Created with Sketch. 1.39MB
TLX Telix Accelerates AI Development with Dedicaid AcquisitionPRICE SENSITIVE27/04/23 download Created with Sketch. 165.18KB
TLX AGM Notice of Meeting, Proxy Form and Online Guide21/04/23 download Created with Sketch. 2.67MB
TLX Q1 2023 Business update to accompany quarterly resultsPRICE SENSITIVE17/04/23 download Created with Sketch. 1.68MB
TLX Appendix 4C and Activities Report - March 2023 QuarterPRICE SENSITIVE17/04/23 download Created with Sketch. 173.05KB
TLX Telix-Grand Pharma Investor Webcast Notification17/04/23 download Created with Sketch. 181.67KB
TLX Telix Preclinical Development of Radiolabelled OlaratumabPRICE SENSITIVE17/04/23 download Created with Sketch. 136.72KB
TLX Notification of upcoming quarterly results and investor call05/04/23 download Created with Sketch. 128.23KB
TLX Notification of cessation of securities - TLX05/04/23 download Created with Sketch. 24.05KB
TLX Cleansing Notice05/04/23 download Created with Sketch. 143.72KB
TLX Notification regarding unquoted securities - TLX
27/03/24 download Created with Sketch. 17.27KB
TLX Cleansing Notice
21/03/24 download Created with Sketch. 141.56KB
TLX Application for quotation of securities - TLX
21/03/24 download Created with Sketch. 15.75KB
TLX Appointment of Darren Patti to Group Chief Operating Officer
12/03/24 download Created with Sketch. 134.78KB
TLX Telix Notice of General Meeting, Proxy Form and Online Guide
06/03/24 download Created with Sketch. 4.52MB
TLX Proposed issue of securities - TLX
05/03/24 download Created with Sketch. 15.86KB
TLX Presentation to Accompany ARTMS Acquisition
05/03/24PRICE SENSITIVE download Created with Sketch. 1.14MB
TLX Telix to Acquire ARTMS (Isotope Production Platform)
05/03/24PRICE SENSITIVE download Created with Sketch. 224.66KB
TLX Proposed issue of securities - TLX
27/02/24 download Created with Sketch. 15.73KB
TLX Telix to Acquire IsoTherapeutics (US R&D and Manufacturing)
27/02/24PRICE SENSITIVE download Created with Sketch. 149.36KB
TLX Appendix 4G and 2023 Corporate Governance Statement
22/02/24 download Created with Sketch. 1.78MB
TLX 2023 Full Year Results Presentation
22/02/24PRICE SENSITIVE download Created with Sketch. 1.33MB
TLX 2023 Full Year Results Release
22/02/24PRICE SENSITIVE download Created with Sketch. 86.93KB
TLX Appendix 4E and 2023 Annual Report
22/02/24PRICE SENSITIVE download Created with Sketch. 12.48MB
TLX Cleansing Notice
09/02/24 download Created with Sketch. 138.55KB
TLX Application for quotation of securities - TLX
09/02/24 download Created with Sketch. 15.76KB
TLX Proposed issue of securities - TLX
08/02/24 download Created with Sketch. 19.52KB
TLX Presentation to Accompany QSAM Acquisition
08/02/24PRICE SENSITIVE download Created with Sketch. 944.1KB
TLX Telix Acquires QSAM and its Bone Cancer Targeting Platform
08/02/24PRICE SENSITIVE download Created with Sketch. 214.84KB
TLX Telix 2023 Full Year Results and Investor Webcast/Call
07/02/24 download Created with Sketch. 138.36KB
TLX Appendix 3Y Change in Director Interests - C Behrenbruch
22/01/24 download Created with Sketch. 286.35KB
TLX Cleansing Notice
22/01/24 download Created with Sketch. 142.52KB
TLX Application for quotation of securities - TLX
22/01/24 download Created with Sketch. 25.63KB
TLX JP Morgan Healthcare Conference Presentation
08/01/24PRICE SENSITIVE download Created with Sketch. 2.11MB
TLX JP Morgan Healthcare Conference and Trading Update
08/01/24PRICE SENSITIVE download Created with Sketch. 175.38KB
TLX Notification regarding unquoted securities - TLX
08/01/24 download Created with Sketch. 28.56KB
TLX Notification of cessation of securities - TLX
08/01/24 download Created with Sketch. 22.34KB
TLX Telix Plans U.S. Registered Public Offering and Listing
05/01/24PRICE SENSITIVE download Created with Sketch. 122.95KB
TLX Cleansing Notice
22/12/23 download Created with Sketch. 142.68KB
TLX Application for quotation of securities - TLX
22/12/23 download Created with Sketch. 27.82KB
TLX Appointment of Dr David Cade to Group Chief Medical Officer
20/12/23 download Created with Sketch. 124.77KB
TLX Telix Submits BLA for TLX250-CDx for Kidney Cancer Imaging
19/12/23PRICE SENSITIVE download Created with Sketch. 187.02KB
TLX Update on Financial Reporting Requirements
18/12/23 download Created with Sketch. 117.69KB
TLX Cleansing Notice
30/11/23 download Created with Sketch. 141.14KB
TLX Application for quotation of securities - TLX
30/11/23 download Created with Sketch. 25.03KB
TLX Telix ProstACT (TLX591) Expert Forum - Webcast Notification
16/11/23 download Created with Sketch. 133.79KB
TLX Telix Announces Proposed Acquisition of QSAM Biosciences
14/11/23PRICE SENSITIVE download Created with Sketch. 141.84KB
TLX First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study
13/11/23PRICE SENSITIVE download Created with Sketch. 141.54KB
TLX Cleansing Notice
10/11/23 download Created with Sketch. 143.09KB
TLX Application for quotation of securities - TLX
10/11/23 download Created with Sketch. 27.88KB
TLX Notification regarding unquoted securities - TLX
02/11/23 download Created with Sketch. 28.14KB
TLX Cleansing Notice
02/11/23 download Created with Sketch. 113.82KB
TLX Application for quotation of securities - TLX
02/11/23 download Created with Sketch. 25.51KB
TLX Telix Completes Acquisition of Lightpoint Medical
01/11/23PRICE SENSITIVE download Created with Sketch. 152.76KB
TLX ProstACT SELECT Study of TLX591 Positive Interim Readout
19/10/23PRICE SENSITIVE download Created with Sketch. 1.12MB
TLX Q3 2023 Business Update to Accompany Quarterly Results
18/10/23PRICE SENSITIVE download Created with Sketch. 1.33MB
TLX Activities Report and Appendix 4C - September 2023 Quarter
18/10/23PRICE SENSITIVE download Created with Sketch. 179.15KB
TLX Notification of cessation of securities - TLX
13/10/23 download Created with Sketch. 22.37KB
TLX Cleansing Notice
13/10/23 download Created with Sketch. 142.64KB
TLX Application for quotation of securities - TLX
13/10/23 download Created with Sketch. 27.79KB
TLX Notification of upcoming quarterly results and investor call
11/10/23 download Created with Sketch. 127.01KB
TLX Cleansing Notice
27/09/23 download Created with Sketch. 143.1KB
TLX Application for quotation of securities - TLX
27/09/23 download Created with Sketch. 28.44KB
TLX Cleansing Notice
06/09/23 download Created with Sketch. 142.93KB
TLX Application for quotation of securities - TLX
06/09/23 download Created with Sketch. 32.13KB
TLX 1H 2023 Results Presentation
23/08/23PRICE SENSITIVE download Created with Sketch. 2.12MB
TLX 1H 2023 Results Release
23/08/23PRICE SENSITIVE download Created with Sketch. 82.77KB
TLX 1H 2023 Appendix 4D and Interim Report
23/08/23PRICE SENSITIVE download Created with Sketch. 1.5MB
TLX Cleansing Notice
16/08/23 download Created with Sketch. 140.39KB
TLX Application for quotation of securities - TLX
16/08/23 download Created with Sketch. 25.04KB
TLX Telix Half Year Results and Investor Conference Call Details
15/08/23 download Created with Sketch. 126.31KB
TLX First Patient Dosed in Phase 3 Illuccix China Study
11/08/23PRICE SENSITIVE download Created with Sketch. 132.49KB
TLX Cleansing Notice
27/07/23 download Created with Sketch. 142.08KB
TLX Application for quotation of securities - TLX
27/07/23 download Created with Sketch. 25.2KB
TLX Q2 2023 Business Update to Accompany Quarterly Results
19/07/23PRICE SENSITIVE download Created with Sketch. 2.54MB
TLX Activities Report and Appendix 4C - June 2023 Quarter
19/07/23PRICE SENSITIVE download Created with Sketch. 191.79KB
TLX Notification of upcoming quarterly results and investor call
13/07/23 download Created with Sketch. 127.16KB
TLX Notification of cessation of securities - TLX
10/07/23 download Created with Sketch. 24.63KB
TLX Notification regarding unquoted securities - TLX
10/07/23 download Created with Sketch. 28.7KB
TLX Cleansing Notice
28/06/23 download Created with Sketch. 140.74KB
TLX Application for quotation of securities - TLX
28/06/23 download Created with Sketch. 27.59KB
TLX Proposed issue of securities - TLX
21/06/23 download Created with Sketch. 30.41KB
TLX Lightpoint Acquisition to Expand Telix Urologic Pipeline
21/06/23PRICE SENSITIVE download Created with Sketch. 204.7KB
TLX Telix Urology Innovation Showcase
21/06/23 download Created with Sketch. 138.59KB
TLX Phase II study for indication expansion of TLX250-CDx doses
19/06/23PRICE SENSITIVE download Created with Sketch. 131.12KB
TLX Appendix 3Y Change in Director Interests - C Behrenbruch
02/06/23 download Created with Sketch. 326.45KB
TLX Notification regarding unquoted securities - TLX
02/06/23 download Created with Sketch. 27.51KB
TLX Cleansing Notice
02/06/23 download Created with Sketch. 140.7KB
TLX Application for quotation of securities - TLX
02/06/23 download Created with Sketch. 27.81KB
TLX Securities Dealing Policy - updated
30/05/23 download Created with Sketch. 273.39KB
TLX Results of Annual General Meeting
24/05/23 download Created with Sketch. 156.03KB
TLX Annual General Meeting - Presentation
24/05/23PRICE SENSITIVE download Created with Sketch. 1.47MB
TLX Annual General Meeting - Chairman and CEO Addresses
24/05/23PRICE SENSITIVE download Created with Sketch. 243.86KB
TLX Notification regarding unquoted securities - TLX
05/05/23 download Created with Sketch. 27.67KB
TLX Cleansing Notice
02/05/23 download Created with Sketch. 143.54KB
TLX Application for quotation of securities - TLX
02/05/23 download Created with Sketch. 34.74KB
TLX Cleansing Notice
01/05/23 download Created with Sketch. 139.17KB
TLX Application for quotation of securities - TLX
01/05/23 download Created with Sketch. 343.52KB
TLX ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses
01/05/23PRICE SENSITIVE download Created with Sketch. 128.28KB
TLX Proposed issue of securities - TLX
27/04/23 download Created with Sketch. 24.75KB
TLX Presentation to Accompany AI Development Program Update
27/04/23PRICE SENSITIVE download Created with Sketch. 1.39MB
TLX Telix Accelerates AI Development with Dedicaid Acquisition
27/04/23PRICE SENSITIVE download Created with Sketch. 165.18KB
TLX AGM Notice of Meeting, Proxy Form and Online Guide
21/04/23 download Created with Sketch. 2.67MB
TLX Q1 2023 Business update to accompany quarterly results
17/04/23PRICE SENSITIVE download Created with Sketch. 1.68MB
TLX Appendix 4C and Activities Report - March 2023 Quarter
17/04/23PRICE SENSITIVE download Created with Sketch. 173.05KB
TLX Telix-Grand Pharma Investor Webcast Notification
17/04/23 download Created with Sketch. 181.67KB
TLX Telix Preclinical Development of Radiolabelled Olaratumab
17/04/23PRICE SENSITIVE download Created with Sketch. 136.72KB
TLX Notification of upcoming quarterly results and investor call
05/04/23 download Created with Sketch. 128.23KB
TLX Notification of cessation of securities - TLX
05/04/23 download Created with Sketch. 24.05KB
TLX Cleansing Notice
05/04/23 download Created with Sketch. 143.72KB
(20min delay)
Last
$12.89
Change
0.030(0.23%)
Mkt cap ! $4.176B
Open High Low Value Volume
$12.91 $13.00 $12.80 $6.611M 512.9K

Buyers (Bids)

No. Vol. Price($)
1 2000 $12.86
 

Sellers (Offers)

Price($) Vol. No.
$12.97 1923 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
$12.86
  Change
0.030 ( 0.19 %)
Open High Low Volume
$12.95 $12.99 $12.80 619089
Last updated 15.59pm 29/03/2024 ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.